What the Research Says About Hormone Therapy, Exercise, and Your Number:
HRT has an inconsistent effect on HRV. Some studies of estrogen therapy show a small rise, others show no change, and regimens that include a progestin tend to lower it. Exercise is different: randomized trials in postmenopausal women raise HRV reliably, with or without hormone therapy. Treat them as two levers that do separate jobs.
Check out HRV+ if you want a simple ritual to support your training regiment.
Key Takeaways
- Hormone therapy and HRV are loosely linked at best. Estrogen alone sometimes nudges HRV up; combined estrogen-progestin regimens and oral routes tend to flatten or lower it.
- Feeling better and HRV can move separately. Hot flash relief does not reliably show up as a higher number, and women with and without hot flashes have similar HRV on average.
- Exercise is the consistent lever. In a 373-woman trial, about the national activity guideline's minimum of moderate exercise raised HRV over six months, and more exercise added little.
- HT use didn't change the exercise effect. Women on and off hormone therapy gained HRV from training equally.
- Use HRV as a readout for both. Build a baseline before any change in therapy, note the date, and bring the weekly trend to your physician.
- Never use HRV to decide on hormone therapy. That decision belongs to you and your physician, based on symptoms and risks HRV can't measure.
Two Levers, One Readout
If you are in the second half of life, you have probably looked at two kinds of numbers at once. One comes from a blood panel and a conversation with your physician about hormone therapy. The other comes from the ring or wristband that reports your heart rate variability every morning.
Many women treat these as one project. The research treats them as two separate levers that each do good work, and that move HRV largely on their own paths.
Heart rate variability (HRV): the small, constant change in the time between heartbeats, measured in milliseconds. Much of it reflects the vagus nerve, the main pathway of the parasympathetic branch that slows the heart and steers the body toward rest and recovery.
Menopausal hormone therapy (HT, often called HRT): prescription estrogen, usually paired with a progestogen for women who still have a uterus. A progestogen is a natural or synthetic form of progesterone that protects the uterine lining.
Soil, roots, and wind
Here is how I explain the two levers to people. Hormone therapy changes the soil. Training grows the roots. HRV tells you how the plant handles the wind.
Better soil can help, and for many women it makes daily life far more comfortable. But the roots that hold steady under load are built by repeated work, and the soil doesn't build them for you.
Does Estrogen Raise HRV?
Sometimes, a little. The strongest support comes from snapshot studies, and the trials that follow women over time are mixed.
A Czech study in Physiological Research compared 925 people at a single point in time: premenopausal women, postmenopausal women without treatment, women on estrogen alone, women on combined estrogen and progesterone, and men. High-frequency HRV, a measure of vagal input, was lower in untreated postmenopausal women than in premenopausal women and women on estrogen alone. Women on combined therapy looked like the untreated group (Physiological Research, 2013). The authors noted that after menopause, women's vagal pattern starts to resemble men's.
A snapshot can't tell you whether the hormones caused the difference, or whether women who choose therapy already differ in other ways. That's where the trials come in.
Some trials found small gains. A study of 46 women found that six months of therapy raised the high-frequency component of HRV (Annals of Noninvasive Electrocardiology, 2001). A short crossover trial found that three weeks of transdermal estradiol slightly increased overall HRV (Fertility and Sterility, 2005).
Others found little or nothing. In a Finnish placebo-controlled trial of 71 women, transdermal estradiol lowered nighttime heart rate without changing standard HRV (Virtanen et al., 2000, Maturitas). A later analysis of the same participants found estrogen slightly reduced the complexity of heart rhythm during deep sleep (Virtanen et al., 2008, Menopause).
Does the Type of Hormone Therapy Matter for HRV?
Yes. Formulation and route appear to matter more than hormone therapy as a category.
The clearest evidence comes from a Finnish placebo-controlled trial of 150 recently postmenopausal women. They were randomized to transdermal estradiol gel, oral estradiol alone, oral estradiol plus the progestin medroxyprogesterone acetate, or placebo for six months. Oral estradiol, especially combined with the progestin, lowered some HRV measures. Transdermal estradiol showed no such effect (Hautamäki et al., 2011, Menopause). That echoes an earlier report in The Lancet linking progestin-containing regimens to reduced HRV (Christ et al., 1999).
Transdermal: delivered through the skin by patch or gel, rather than swallowed as a pill (oral).
This is a reason to note your exact regimen alongside your HRV data, not a reason to change it. Route and formulation are chosen for many reasons HRV can't see, and that choice belongs to you and your physician.
Do Hot Flashes Show Up in Your HRV?
Not reliably, on average. Feeling better and HRV appear to run on separate tracks.
A 2026 systematic review from the University of Calgary pooled the studies comparing women with and without vasomotor symptoms, the hot flashes and night sweats of menopause. It found no consistent difference in HRV between the groups, though the studies varied widely in method (Hira et al., 2026, Physiological Reports). In a separate Finnish trial, hormone therapy didn't meaningfully change HRV under controlled lab conditions in women with or without hot flashes (Hautamäki et al., 2013, Climacteric).
Some individual studies do report lower HRV in women with more severe symptoms. But the overall picture is that symptom relief and autonomic tone don't move in lockstep. If your hot flashes ease on therapy and your number doesn't budge, that is a common pattern.
Does Exercise Raise HRV After Menopause?
Yes, and it is the lever with the most consistent evidence in this stage of life.
At the Cooper Institute, Radim Jurca and colleagues randomized 88 sedentary postmenopausal women to moderate aerobic exercise or a control group. After eight weeks, the exercise group raised every absolute HRV measure and lowered resting heart rate. Hormone therapy use did not change the benefit (Jurca et al., 2004, American Heart Journal).
The larger DREW trial asked how much exercise it takes. Researchers randomized 373 sedentary postmenopausal women aged 45 to 75 to no exercise or to one of three moderate doses, at about half of aerobic capacity, for six months. Vagal HRV rose with exercise. The dose matching roughly the national minimum activity recommendation produced a clear gain. Half that dose fell short, and half again more added nothing further (Earnest et al., 2008, PLOS One).
Moderate intensity: effort where you can talk in full sentences but would rather not sing. In DREW, about 50% of each woman's aerobic capacity.
That last finding is the part I want every woman in this stage of life to hear. You don't need extreme training to move this number. You need the guideline dose, done consistently.
Hormone therapy vs. exercise: what each lever does
| Hormone therapy | Exercise | |
|---|---|---|
| What it's for | Menopausal symptoms and the conditions it is prescribed for | Fitness, strength, and autonomic capacity |
| Effect on HRV | Inconsistent: small rise, no change, or a drop depending on formulation and route | Consistent rise in randomized trials |
| Time course | Varies; often no visible change | Weeks to months |
| Interaction | Did not change the HRV benefit of exercise | Works with or without hormone therapy |
| Who decides | You and your physician | You, every day |
What About the Bigger Cardiovascular Picture?
The large trials show what hormone therapy does and doesn't cover, and those numbers belong in the conversation with your physician.
A 2024 meta-analysis pooled 33 randomized trials covering 44,639 postmenopausal women. Overall, hormone therapy did not lower deaths or cardiovascular events, and it came with higher rates of stroke and blood clots. The picture changed with timing: women who started within about ten years of menopause showed more favorable outcomes than women who started later (Gu et al., 2024, BMC Women's Health).
That is why hormone therapy decisions turn on your age, your time since menopause, your symptoms and your personal risk profile. None of that shows up on a ring. Hormone therapy earns its place for what it treats. Training earns its place on the autonomic side, and it is yours to run every day.
If your partner is on TRT
Men see a similar split. In a Polish study, nine weeks of testosterone in 30 men with low testosterone and metabolic syndrome raised overall HRV, though values stayed below those of healthy men and there was no placebo group (Poliwczak et al., 2013, Polish Archives of Internal Medicine). TRAVERSE, a placebo-controlled trial of 5,246 men aged 45 to 80, found testosterone did not raise major cardiac events, but it did come with higher rates of atrial fibrillation, pulmonary embolism and acute kidney injury (Lincoff et al., 2023, New England Journal of Medicine). The same advice applies: exercise is the dependable autonomic lever, and the hormone conversation belongs with a physician.
How to Use HRV to Watch Both Levers
Track a baseline first, log every change, and read the weekly trend, not the morning.
| Step | What to do | Why |
|---|---|---|
| 1. Build a baseline | Collect three to four weeks of readings before you start or change hormone therapy or a training plan | You need your own normal to compare against |
| 2. Log every change | Note the date of any start, stop, dose change, or change in route, and any new training block | So a shift in the trend can be matched to its likely cause |
| 3. Read the weekly average | Compare each week's average with your baseline, not single mornings | Day-to-day noise is large; three to four days of data begin to show a real trend |
| 4. Expect different timelines | Training tends to move HRV over weeks; hormone therapy may move it a little, not at all, or the other way | A flat line on therapy is common and isn't a verdict |
| 5. Share the trend | Bring the weekly trend and your log to your physician | A shift either way is information to discuss, not a reason to change therapy on your own |
Atrial fibrillation: an irregular heart rhythm. Ring and wrist HRV becomes unreliable when the rhythm is irregular.
One caution. Your wearable's HRV can't stand in for a check of your heart rhythm. If you notice palpitations, a racing or irregular heartbeat, or your device flags an irregular rhythm, see your physician. And talk with your physician before you start, stop or change any hormone therapy.
What I Watch For
Across decades of coaching, I have watched people pin everything on one intervention and get frustrated when it didn't do two jobs at once. Hormone therapy addresses the symptoms and deficiencies it is prescribed for. Training builds an autonomic capacity that the hormone studies show only inconsistently. Doing both means you aren't asking either one to do the other's work.
Go Deeper: The HRV Book
I wrote The HRV Book for people who already wear the device and want to know what to do with it. It covers how to build a baseline you can trust, how to separate a real change from ordinary day-to-day noise, and the behaviors, from training load to sleep and breathing, that the research says move the number.
Frequently Asked Questions
Does HRT affect HRV? Inconsistently. Some studies of estrogen therapy show a small increase in HRV, others show no change, and regimens that include a progestin or are taken orally have been linked to lower HRV. Exercise raises HRV more reliably than hormone therapy does.
Does HRV go down during menopause? On average, vagal HRV is lower in postmenopausal women than in premenopausal women, and it continues to decline with age. Your own trend matters more than population averages, because HRV varies widely between healthy people.
Does transdermal estrogen affect HRV differently than oral? In a placebo-controlled trial of 150 women, oral estradiol, especially with a progestin, lowered some HRV measures while transdermal estradiol did not. Route is chosen for many reasons beyond HRV, so discuss any change with your physician.
Will my HRV go up when my hot flashes improve? Not necessarily. Studies find similar average HRV in women with and without hot flashes, and symptom relief on hormone therapy often comes without a change in HRV.
How much exercise does it take to raise HRV after menopause? In the DREW trial of 373 postmenopausal women, moderate exercise at roughly the national minimum activity recommendation raised HRV over six months. Half that amount fell short, and more added little.
Should I use my HRV to decide whether to start or stop HRT? No. Hormone therapy decisions depend on symptoms, age, time since menopause and personal risk factors that HRV can't measure. Use HRV as a trend to share with your physician, not as a deciding factor.
Sources
- Estrogen can modulate menopausal women's heart rate variability (2013). Physiological Research, 62(Suppl 1), S165–S171.
- Effects of hormone replacement therapy on heart rate variability in postmenopausal women (2001). Annals of Noninvasive Electrocardiology, 6(4), 280–284.
- Short-term effect of transdermal estrogen on autonomic nervous modulation in postmenopausal women (2005). Fertility and Sterility.
- Virtanen I, et al. (2000). The effect of estrogen replacement therapy on cardiac autonomic regulation. Maturitas.
- Virtanen I, Ekholm E, Polo-Kantola P, Hiekkanen H, Huikuri H (2008). Postmenopausal estrogen therapy modulates nocturnal nonlinear heart rate dynamics. Menopause, 15, 693–697.
- Hautamäki H, et al. (2011). Vasomotor hot flashes and heart rate variability: a placebo-controlled trial of postmenopausal hormone therapy. Menopause.
- Christ M, Seyffart K, Wehling M (1999). Attenuation of heart-rate variability in postmenopausal women on progestin-containing hormone replacement therapy. The Lancet.
- Hira R, Uppal J, Deol P, Porter D, Exner D, Raj SR, Baker JR (2026). A systematic review of heart rate variability and menopausal vasomotor symptoms. Physiological Reports, 14(9), e70907.
- Hautamäki H, et al. (2013). Menopausal hot flushes do not associate with changes in heart rate variability in controlled testing: a randomized trial on hormone therapy. Climacteric.
- Jurca R, Church TS, Morss GM, Jordan AN, Earnest CP (2004). Eight weeks of moderate-intensity exercise training increases heart rate variability in sedentary postmenopausal women. American Heart Journal, 147(5), e8–e15.
- Earnest CP, Lavie CJ, Blair SN, Church TS (2008). Heart rate variability characteristics in sedentary postmenopausal women following six months of exercise training: the DREW study. PLOS One, 3, e2288.
- Gu Y, Han F, Xue M, Wang M, Huang Y (2024). The benefits and risks of menopause hormone therapy for the cardiovascular system in postmenopausal women: a systematic review and meta-analysis. BMC Women's Health, 24, 60.
- Poliwczak AR, Tylińska M, Broncel M (2013). Effect of short-term testosterone replacement therapy on heart rate variability in men with hypoandrogen-metabolic syndrome. Polish Archives of Internal Medicine, 123, 467–473.
- Lincoff AM, et al. (2023). Cardiovascular safety of testosterone-replacement therapy. New England Journal of Medicine, 389, 107–117.
- Moxley D (2025). The HRV Book: What Your Ring or Wristband Is Actually Telling You and What You Can Do to Change It!
This article is for educational purposes and is not medical advice. It does not recommend starting, stopping, or changing any hormone therapy. Talk with your physician about any treatment decision.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.